01 January 2009
The influence of commonly used immunosuppressive drugs on the small bowel functions – A comparative experimental study
Maciej Malinowski, Peter Martus, Peter Neuhaus, Martin StockmannAnn Transplant 2009; 14(2): 38-44 :: ID: 880531
Abstract
Background: Gastrointestinal side effects of immunosuppressive drugs have got a high importance in clinical practice. The aim of this basic experimental study was to characterize the direct and immediate influence of seven commonly used immunosuppressive drugs on the small bowel functions. Therefore, the influence of ciclosporin A, tacrolimus, mycophenolate mofetil, enteric coated MPA, sirolimus, everolimus and FTY720 on-glucose absorption (I-GLU), chloride secretion (I-CHL), and barrier function (I-BAR) was investigated.
Material/Methods: Jejunum of Wistar rats was mounted into modified Ussing-chambers and thereafter incubated with a low (therapeutic) or high (toxic) concentration of immunosuppressive drugs for one hour. I-GLU was measured by 3-O-methyl-D-glucopyranose kinetics. I-CHL was assessed through basal, bumetanide inhibited and theophylline + PgE[sub]2 [/sub]activated short circuit current difference. I-BAR was assessed by transepithelial resistance and[sup] 3[/sup]H-Lactulose-Flux.
Results: No differences were observed within the analyzed parameters whether immunosuppressive drugs were added from mucosal or serosal intestine side. The glucose absorption was not influenced by any of the analyzed immunosuppressive drugs. The small intestine barrier function was diminished by everolimus in the toxic group only. Only mycophenolate mofetil and EC-MPA decreased chloride secretion in the toxic concentration. None of the analyzed drugs increased chloride secretion.
Conclusions: In conclusion, the analyzed immunosuppressive drugs had no direct and immediate influence on gastrointestinal function in therapeutic concentrations. However, toxic concentrations of mycophenolate mofetil, enteric coated MPA, and everolimus might be of importance for local effects on small bowel function due to oral application.
Keywords: immunosuppressive drugs, gastrointestinal side effects, Fifth Followup Wellspring, Obesity-related glomerulopathy, secondary FSGS, obesity-related glomerulopathy
In Press
08 Mar 2024 : Original article
Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...Ann Transplant In Press; DOI: 10.12659/AOT.943532
14 Mar 2024 : Original article
Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort StudyAnn Transplant In Press; DOI: 10.12659/AOT.943652
14 Mar 2024 : Case report
Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...Ann Transplant In Press; DOI: 10.12659/AOT.942358
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860